leadf
logo-loader
AIM:APH FRA:DVL

Alliance Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£400.74 m
Price
75.30 GBX
Change
-0.13%
52 weeks high
88.90
52 weeks low
52.17

In brief

We are an alliance

A leading international healthcare business of inter-connected people and brands. A global range of products delivering outstanding value.

We own or licence the rights to more than 90 pharmaceuticals and consumer healthcare products. Promotion investment is focused on a small number of brands with significant international or multi-territory reach.

Alliance sells its products in more than 100 countries. The Group's proven business model allows it to benefit both from organic growth opportunities and from enhancing its growth rate through carefully selected acquisitions.

Snapshot

  • Owns a portfolio of prescription and OTC brands
  • Integrating Nizoral acquisition from Johnson & Johnson 
  • Strong cash generation

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Alliance Pharma: Star brands and Asia underpin drugs group's financial performance

The company said it was on track to hit full-year expectations as it delivered a solid first-half performance

on 09/24/2019